173 related articles for article (PubMed ID: 36969270)
1. Dose-dependent effects of human umbilical cord-derived mesenchymal stem cell treatment in hyperoxia-induced lung injury of neonatal rats.
Xiong J; Ai Q; Bao L; Gan Y; Dai X; Han M; Shi Y
Front Pediatr; 2023; 11():1111829. PubMed ID: 36969270
[TBL] [Abstract][Full Text] [Related]
2. Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats.
Chou HC; Chang CH; Chen CH; Lin W; Chen CM
Stem Cell Res Ther; 2021 May; 12(1):258. PubMed ID: 33933128
[TBL] [Abstract][Full Text] [Related]
3. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury
Dong N; Zhou PP; Li D; Zhu HS; Liu LH; Ma HX; Shi Q; Ju XL
World J Stem Cells; 2022 Jul; 14(7):556-576. PubMed ID: 36157523
[TBL] [Abstract][Full Text] [Related]
4. Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6.
Chaubey S; Thueson S; Ponnalagu D; Alam MA; Gheorghe CP; Aghai Z; Singh H; Bhandari V
Stem Cell Res Ther; 2018 Jun; 9(1):173. PubMed ID: 29941022
[TBL] [Abstract][Full Text] [Related]
5. Surfactant effects on the viability and function of human mesenchymal stem cells: in vitro and in vivo assessment.
Chen CM; Chou HC; Lin W; Tseng C
Stem Cell Res Ther; 2017 Aug; 8(1):180. PubMed ID: 28774314
[TBL] [Abstract][Full Text] [Related]
6. Human mesenchymal stem cells attenuate hyperoxia-induced lung injury through inhibition of the renin-angiotensin system in newborn rats.
Chen CM; Chou HC
Am J Transl Res; 2018; 10(8):2628-2635. PubMed ID: 30210699
[TBL] [Abstract][Full Text] [Related]
7. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
Chou HC; Li YT; Chen CM
Am J Transl Res; 2016; 8(2):342-53. PubMed ID: 27158330
[TBL] [Abstract][Full Text] [Related]
8. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats.
Chang YS; Choi SJ; Sung DK; Kim SY; Oh W; Yang YS; Park WS
Cell Transplant; 2011; 20(11-12):1843-54. PubMed ID: 23167961
[TBL] [Abstract][Full Text] [Related]
9. Comparative Effects of Bone Marrow-derived Versus Umbilical Cord Tissue Mesenchymal Stem Cells in an Experimental Model of Bronchopulmonary Dysplasia.
Benny M; Courchia B; Shrager S; Sharma M; Chen P; Duara J; Valasaki K; Bellio MA; Damianos A; Huang J; Zambrano R; Schmidt A; Wu S; Velazquez OC; Hare JM; Khan A; Young KC
Stem Cells Transl Med; 2022 Mar; 11(2):189-199. PubMed ID: 35298658
[TBL] [Abstract][Full Text] [Related]
10. [Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats].
Wang XL; Xue XD
Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):446-51. PubMed ID: 19951473
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.
Chang YS; Oh W; Choi SJ; Sung DK; Kim SY; Choi EY; Kang S; Jin HJ; Yang YS; Park WS
Cell Transplant; 2009; 18(8):869-86. PubMed ID: 19500472
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
[TBL] [Abstract][Full Text] [Related]
13. Human placenta-derived mesenchymal stem cells attenuate established hyperoxia-induced lung injury in newborn rats.
Chou HC; Chen CM
Pediatr Neonatol; 2020 Oct; 61(5):498-505. PubMed ID: 32564932
[TBL] [Abstract][Full Text] [Related]
14. Adipose Stem Cells Derived Exosomes Alleviate Bronchopulmonary Dysplasia and Regulate Autophagy in Neonatal Rats.
Sun Y; Chen C; Liu Y; Sheng A; Wang S; Zhang X; Wang D; Wang Q; Lu C; Lin Z
Curr Stem Cell Res Ther; 2024; 19(6):919-932. PubMed ID: 37817518
[TBL] [Abstract][Full Text] [Related]
15. Cathelicidin attenuates hyperoxia-induced lung injury by inhibiting oxidative stress in newborn rats.
Jiang JS; Chou HC; Chen CM
Free Radic Biol Med; 2020 Apr; 150():23-29. PubMed ID: 32057991
[TBL] [Abstract][Full Text] [Related]
16. Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats.
Kim YE; Park WS; Sung DK; Ahn SY; Sung SI; Yoo HS; Chang YS
Pediatr Res; 2016 Sep; 80(3):415-24. PubMed ID: 27064241
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.
Xie Y; Chen F; Jia L; Chen R; Zhang VW; Zhong X; Wang D
J Cell Mol Med; 2021 Sep; 25(17):8558-8566. PubMed ID: 34322990
[TBL] [Abstract][Full Text] [Related]
18. Maternal Tn Immunization Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats Through Suppression of Oxidative Stress and Inflammation.
Chen CM; Hwang J; Chou HC
Front Immunol; 2019; 10():681. PubMed ID: 31019509
[TBL] [Abstract][Full Text] [Related]
19. Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia.
Guerra K; Bryan C; Dapaah-Siakwan F; Sammour I; Drummond S; Zambrano R; Chen P; Huang J; Sharma M; Shrager S; Benny M; Wu S; Young KC
Respir Res; 2019 Nov; 20(1):255. PubMed ID: 31718614
[TBL] [Abstract][Full Text] [Related]
20. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury.
Chang YS; Choi SJ; Ahn SY; Sung DK; Sung SI; Yoo HS; Oh WI; Park WS
PLoS One; 2013; 8(1):e52419. PubMed ID: 23349686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
